All too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in the belief that this is the only area that can determine success.
We all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies that are developing patient support programmes.
The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course better revenues for pharma are all possible.
Overview
Medical affairs and publications teams are under increasing pressure to demonstrate effectively the success of the medical communications activities they undertake.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho